Journal Title：Maternalfetal Medicine

Since its inception, MFM has achieved significant development results. It has not only been included in multiple internationally renowned databases such as ESCI (Emerging Sources Citation Index), Scopus, Embase, etc., but also achieved its first impact factor of 1.0 in 2023, demonstrating its continuous improvement in academic quality and influence. The journal covers various aspects such as pregnancy complications, prenatal screening and diagnosis, fetal treatment, basic research, and imaging research, providing abundant academic resources for scholars in the field of maternal and fetal medicine.

In addition, MFM actively organizes high-quality domestic and international brand academic conferences, such as the China Maternal and Fetal Medicine Forum, providing valuable opportunities for scholars to exchange ideas and share research results. These efforts have not only promoted academic exchanges and cooperation in the field of maternal and fetal medicine, but also made important contributions to the development of maternal and fetal medicine in China.

自創刊以來，MFM取得了顯著的發展成果。它不僅被ESCI（Emerging Sources Citation Index）、Scopus、Embase等多個國際知名數據庫收錄，還在2023年獲得了首個影響因子1.0，顯示出其學術質量和影響力的不斷提升。期刊內容涵蓋妊娠并發癥、產前篩查與診斷、胎兒治療、基礎研究、影像學研究等多個方面，為母胎醫學領域的學者提供了豐富的學術資源。

此外，MFM還積極舉辦高質量的國內、國際品牌學術會議，如中國母胎醫學論壇等，為學者們提供了交流思想、分享研究成果的寶貴機會。這些努力不僅推動了母胎醫學領域的學術交流與合作，也為中國母胎醫學的發展做出了重要貢獻。

Maternalfetal Medicine由Wolters Kluwer Health出版商出版，收稿方向涵蓋Medicine - Obstetrics and Gynecology全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 10 Weeks ，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。